HSR26-210: Patient Characteristics and Survival Outcomes in FLT3 Internal Tandem Duplication (ITD) vs. FLT3 Tyrosine Kinase Domain (TKD) Mutated AML: Insights from a Real-World Cohort
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
HSR26-210: Patient Characteristics and Survival Outcomes in FLT3 Internal Tandem Duplication (ITD) vs. FLT3 Tyrosine Kinase Domain (TKD) Mutated AML: Insights from a Real-World Cohort | Researchclopedia